Source: Chuck Abbott, SUCCESSFUL FARMING, 3/2/20


Six firms are seeing disruptions in the supply chain because of Covid-19 that could lead to shortages of animal drugs for the U.S. market, said the FDA in an update. Some 32 animal drug companies make finished drugs or buy active pharmaceutical ingredients in China for use in the United States, said FDA commissioner Stephen Hahn late last week. “The FDA has contacted all 32 firms and no shortages have been reported at this time. However, six of those firms have indicated that they are seeing disruptions in the supply chain that soon could lead to shortages.

For more of this story, click here.